Form Type: 4

SEC EDGAR Link
Accession Number:0001781002-20-000005
Date:2020-02-04
Issuer: DURECT CORP (DRRX)
Original Submission Date:

Reporting Person:

BLEICHROEDER LP
1345 AVENUE OF THE AMERICAS
47TH FLOOR NEW YORK, NY 10105

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-02-04 P 77,500 a $1.70 26,554,046 indirect f2
COMMON STOCK 2020-02-05 P 74,998 a $1.69 26,629,044 indirect f2
COMMON STOCK 2020-02-06 P 75,000 a $1.65 26,704,044 indirect f2
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reported price in column 4 is a weighted average price. these shares were bought in multiple transactions. on 02/04/2020, prices ranged from $1.68 to $1.71 per share, inclusive. on 02/05/2020, prices ranged from $1.675 to $1.70 per share, inclusive. on 02/06/2020, prices ranged from $1.605 to $1.69 per share, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or to the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
f2 the shares of common stock reported herein are indirectly beneficially owned by bleichroeder, lp (bleichroeder), a delaware limited partnership, an investment adviser registered under the investment advisers act of 1940. bleichroeder is the registered investment adviser to biotechnology master fund, ltd. as well as to 21 april fund, lp and 21 april fund, ltd. (collectively, the "funds"). the shares of common stock reported herein are directly held by the funds and other managedaccounts. bleichroeder disclaims beneficial ownership of the shares of common stock held directly by the funds and other managed accounts except to the extent, if any, of its pecuniary interest therein, and this report shall not be deemed an admission that bleichroeder is the beneficial owner of any such securities.
WhaleWisdom Logo

Elevate your investments